| Patient | Josephine Baker |
|---|---|
| Date of birth | 1906-06-03 |
| Identifiers | MRN HR-ML049-SYN-TD; SSN (made up) 000-49-3172 |
| Document date | 1969-05-26 |
| Author | Colette Ashby-Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week review after the change to clopidogrel. [S]
Ms. Baker returns four weeks after ticagrelor was changed to clopidogrel. She took the loading dose as written, and within a week the episodes of air hunger stopped. She has completed ten cardiac rehabilitation sessions, now walks on the treadmill for 30 minutes at a brisk pace, and has begun light stretching and dance steps with the physiotherapist's approval. Her home blood pressure averages 124/76 on lisinopril 10 mg. She did not have the blood tests ordered for one to two weeks after the last visit (potassium, creatinine and lipids): the order went to the clinic laboratory, and she did not have a ride on the days it was open. She has had no lightheadedness, cough or bleeding. She met the social worker, who is helping her plan the repayment of her debts. She feels more like herself. [S]
| Element | Detail |
|---|---|
| Breathlessness | Resolved within a week of stopping ticagrelor |
| Rehabilitation | Ten sessions; 30 minutes brisk treadmill walking |
| Home blood pressure | Average 124/76 mmHg |
| Missed tests | Metabolic panel and lipid panel ordered for one to two weeks after the last visit not done; no ride to the clinic laboratory |
| Seattle Angina Questionnaire-7 | 84, from 70 |
| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No air hunger or breathlessness; no cough |
| Cardiovascular | Negative | No chest pain, palpitations or lightheadedness |
| Hematologic/lymphatic | Negative | No bleeding or unusual bruising |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Ticagrelor 90 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily | One tablet daily after a 600 mg loading dose | Oral route | 1969-04-28 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Lisinopril 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-04-28 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 1969-03-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-05-26 | Body height | 168 | cm | S |
| 1969-05-26 | Body weight | 59.9 | kg | S |
| 1969-05-26 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 1969-05-26 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1969-05-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1969-05-26 | Heart rate | 60 | /min | S |
| 1969-05-26 | Respiratory rate | 14 | /min | S |
| 1969-05-26 | Body temperature | 36.6 | Cel | S |
| 1969-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-05-26 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1969-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-05-26 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-05-26 | Overall summary score [SAQ] | 84 | {score} | S |
Vital signs recorded on 1969-05-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 126/78, pulse 60; weight 59.9 kg |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Extremities | No edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor. |
| Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912 | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history. |
| High blood pressure, found during the hospital stay for the heart attack | active | confirmed | I10 | S — Synthetic modern diagnosis; no claim about her real blood pressure. |
| Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | active | provisional | Z90.710 | S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source. |
| Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel | resolved | confirmed | T45.525A | S — Synthetic diagnosis at the second visit; resolved at the third visit after the switch. |
| Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor | active | confirmed | E78.41 | S — Synthetic result measured once at the second visit. |
| Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers | active | confirmed | Z59.86 | S — Synthetic social need anchored to her documented debts and the loss of Les Milandes. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure (seated, average of two readings; home readings) | Every visit | Completed today | 126/78 mmHg; home average 124/76 |
| Examination | Weight, BMI and physical activity | Every visit | Completed today | 59.9 kg; ten rehabilitation sessions, 30 minutes brisk walking |
| Medication safety | Adherence: aspirin and P2Y12 inhibitor through the dual antiplatelet window, high-intensity statin, beta-blocker, ACE inhibitor | Every visit | Completed today | No missed doses of aspirin, clopidogrel, atorvastatin, metoprolol or lisinopril |
| Medication safety | Bleeding on dual antiplatelet therapy (symptoms, hemoglobin when indicated) | Every visit | Completed today | No bleeding or bruising |
| Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | One to two weeks after a start or dose change, then every six to twelve months | Deferred | The panel due one to two weeks after lisinopril was raised to 10 mg was missed: the order went to the clinic laboratory and she had no ride on its opening days. It was drawn today, four weeks after the change: potassium 4.7 mmol/L and creatinine 0.88 mg/dL (eGFR 74), so no harm resulted. Corrective action: laboratory tests drawn at the rehabilitation center on session days |
| Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | One to two weeks after a start or dose change, then every six to twelve months | Completed today | Sodium 140, potassium 4.7, creatinine 0.88 mg/dL (eGFR 74), glucose 92 |
| Laboratory | Lipid panel | Four to eight weeks after a statin start or change, then every three to twelve months | Deferred | The panel due four to eight weeks after the statin start was missed with the same laboratory trip and, by oversight, was not added to today's blood test. Corrective action: added to the standing order at the rehabilitation center and to the twelve-week review; harm is judged on that result |
| Survey | Angina status (Seattle Angina Questionnaire-7) | At intake and every few months in the first year | Completed today | 84, from 70 |
| Survey | Depression screen (PHQ-2, then PHQ-9) | After the infarction and periodically | Up to date | PHQ-9 7 at intake; repeat at about twelve weeks |
| Imaging | Echocardiogram for left ventricular function | After the infarction if not done or if function was reduced; then only with clinical change | Not indicated | Ejection fraction 52% five weeks after the infarction; no clinical change |
| Examination | ECG and troponin | Only with new or changing symptoms | Not indicated | No new symptoms |
| Referral | Cardiac rehabilitation | Within weeks of the infarction; 36 sessions | Completed today | Ten of 36 sessions completed |
| Self-management | Self-management: chest-pain action plan, nitroglycerin, women's warning symptoms | Every visit | Completed today | Action plan reviewed; nitroglycerin not needed |
| Medication safety | Medicine and visit costs | Every visit | Completed today | Generic medicines in 90-day fills; social worker helping with a repayment plan |
Goal progress:
Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026)
Follow-up: Twelve-week review in eight weeks with an exercise test, a lipid panel and a PHQ-9, drawn and done at the rehabilitation center where possible. Call 911 for chest pain not relieved five minutes after one nitroglycerin. Next scheduled visit 1969-07-21: twelve-week review: exercise test, lipids, mood, and the return to performing. [S]